万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://www.journals.elsevier.com/diagnostic-microbiology-and-infectious-disease
3、投稿网址：
https://www.editorialmanager.com/dmid/default.aspx
4、期刊刊期：月刊，一年出版12期。
2021年8月5日星期四
投稿须知【官网信息】
Guide for Authors
Diagnostic Microbiology and Infectious Disease also covers such areas as laboratory and clinical management of microbial diseases, epidemiology and pathogenesis of infections, automation in the diagnostic microbiology laboratory, and antibiotic susceptibility testing. Animal studies will only be considered if they specifically address infectious diseases, laboratory assays or antimicrobial agents relevant to human infectious diseases.
Diagnostic Microbiology and Infectious Disease keeps you informed of the latest developments in clinical microbiology and the diagnosis and treatment of infectious diseases. Packed with rigorously peer-reviewed articles and studies in bacteriology, immunology, immunoserology, infectious diseases, mycology, parasitology, and virology. The journal examines new procedures, unusual cases, controversial issues, and important new literature.
Diagnostic Microbiology and Infectious Disease's distinguished independent editorial board, consisting of experts from many medical specialties, ensures you extensive and authoritative coverage.
Diagnostic Microbiology and Infectious Disease features:
- Informed commentaries on new antibiotics
- Rapid and cost-effective methods in the laboratory
- Instructive case studies with emphasis on complex circumstances
- Insightful editorials on important current issues
- Book reviews that keep you up-to-date on recently published literature.
Diagnostic Microbiology and Infectious Disease also covers such areas as laboratory and clinical management of microbial diseases, epidemiology and pathogenesis of infections, automation in the diagnostic microbiology laboratory, and antibiotic susceptibility testing. Animal studies will only be considered if they specifically address infectious diseases, laboratory assays or antimicrobial agents relevant to human infectious diseases.
Types of papers
Papers may be submitted that are full-length articles (including subject review articles) or short reports. All manuscripts must comply with the required format and word count described in the “Guide for Authors”. Any deviation from these instructions may result in immediate rejection. Please note that all manuscripts are checked for plagiarism upon submission. The Editor-in-Chief reserves the right to reject any manuscript that has too high a level of similarity to other published works.
Submission checklist
Please use this list to carry out a final check of your submission before you send it to the journal for review. It is required that all new submissions are submitted with a completed Checklist for Initial Submission (available at: https://www.elsevier.com/__data/promis_misc/DMID-ChecklistInitialSubmissions.docx).
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
All necessary files have been uploaded:
Checklist for Initial Submission is a mandatory file to be submitted in the original submission
Abstract:
• A concise and factual abstract is required. It should be 150 words or less for full-length papers and 50 words or less for notes. The abstract should state briefly the purpose of the research, the principal results and major conclusions. An abstract is often presented separately from the article, so it must be able to stand alone. For this reason, References should be avoided, but if essential, then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself.
Manuscript:
• To avoid unnecessary errors, you are strongly advised to use the spell check and grammar check functions of your word processor.
•Please include line and page numbers in your manuscript file
• Include keywords
• All figures (include relevant captions)
• All tables (including titles, description, footnotes)
• Ensure all figure and table citations in the text match the files provided
• Indicate clearly if color should be used for any figures in print
Cover letter (The cover letter should explain why the submitted work is unique/novel, how it contributes to the body of knowledge about the topic, why it is appropriate for DMID, and why it would be of interest to DMID readers.)
ICMJE Conflict of Interest Disclosure Form (DMID upholds the most rigorous standards of transparency, as defined by the International Committee of Medical Journal Editors [ICMJE]. Each online submission must be accompanied by a Conflict of Interest Disclosure Form: http://icmje.org/downloads/coi_disclosure.docx.)
Graphical Abstracts / Highlights files (where applicable)
Supplemental files (where applicable)
Further considerations
• Manuscript has been 'spell checked' and 'grammar checked'
• All references mentioned in the Reference List are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Internet)
• A competing interests statement is provided, even if the authors have no competing interests to declare
• Journal policies detailed in this guide have been reviewed
• Referee suggestions and contact details provided. Suggested reviewers should not be from the same institution of the authors, at least 2 of 5 should be from institutions outside the authors own country, have no conflicts of interest with the authors (including previously published co-authored papers or funded grants in the last 3 years), and be internationally recognized and published in the field under study.
Ethics in publishing
Please see our information on Ethics in publishing.
Reporting guidelines
Certain research designs should be reported in DMID articles according to reporting guidelines: CONSORT for randomized controlled trials; STROBE for observational studies (including its extensions, STROME-ID for reporting of molecular epidemiology for infectious diseases and STROBE-AMS for reporting epidemiological studies on antimicrobial resistance); PRISMA for systematic reviews and meta-analysis; STARD for diagnostic studies; CHEERS for economic evaluations; and ORION for outbreak reports and interventional, non-randomized studies of nosocomial infections. The appropriate checklist should be submitted at the time of the article submission. All reporting guidelines can be found at the EQUATOR network site: http://www.equator-network.org/reporting-guidelines
Studies in humans and animals
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.
Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.
Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyrightholder. To verify originality, all articles will be checked by the originality detection service Crossref Similarity Check. The Editor-in-Chief reserves the right to reject any manuscript that has too high a level of similarity to other published works.
Preprints
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.
Author contributions
For transparency, we require authors to submit an author statement file outlining their individual contributions to the paper using the relevant CRediT roles: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing - original draft; Writing - review & editing. Authorship statements should be formatted with the names of authors first and CRediT role(s) following. More details and an example
Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
Article transfer service
This journal is part of our Article Transfer Service. This means that if the Editor feels your article is more suitable in one of our other participating journals, then you may be asked to consider transferring the article to one of those. If you agree, your article will be transferred automatically on your behalf with no need to reformat. Please note that your article will be reviewed again by the new journal. More information.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases.
For gold open access articles: Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (more information). Permitted third party reuse of gold open access articles is determined by the author's choice of user license.
Author rights
As an author you (or your employer or institution) have certain rights to reuse your work. More information.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
Open access
Please visit our Open Access page for more information.
Elsevier Researcher Academy
Researcher Academy is a free e-learning platform designed to support early and mid-career researchers throughout their research journey. The "Learn" environment at Researcher Academy offers several interactive modules, webinars, downloadable guides and resources to guide you through the process of writing for research and going through peer review. Feel free to use these free resources to improve your submission and navigate the publication process with ease.
Language (usage and editing services)
Please write your text in good American English. Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's WebShop https://webshop.elsevier.com/language-editing-services/language-editing/ or visit our customer support site https://service.elsevier.com for more information.
Submission
Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.
Submit your article
Please submit your article via https://www.editorialmanager.com/dmid.
Please submit, with the manuscript, the names, addresses and e-mail addresses of five or more potential referees who are not conflicted with the author's work. Potential reviewers should also have significant knowledge or experience with the topic, and have published in the subject matter area as well within the last three years in an international peer review journal. Moreover, potential reviewers must not be from the same institute as any of the authors, and only two of five can be selected from the same country/region of the corresponding author. Note that the editor retains the sole right to decide whether or not the suggested reviewers are used.
Additional information
Authors are requested to submit the text, tables, and artwork in electronic form (not as a PDF) to https://www.editorialmanager.com/dmid. In an accompanying letter, authors should state that the manuscript, or parts of it, have not been and will not be submitted elsewhere for publication. The letter is also required to state why the submitted work advances the field under study and why it is important for the DMID readership. Manuscripts not providing this information in the accompanying letter will be returned to the authors.
……
更多详情：
https://www.elsevier.com/journals/diagnostic-microbiology-and-infectious-disease/0732-8893/guide-for-authors
